Trump Declares 100% Tariff on Pharma Imports from October 1; India Braces for Impact

Support Independent Journalism

Support Goemkarponn’s mission for fearless journalism. Donate Now

New Delhi: US President Donald Trump has announced a fresh round of tariffs, declaring a 100 per cent duty on imports of branded and patented pharmaceutical products starting October 1. The move could have far-reaching implications for India’s pharmaceutical sector, which counts the United States as its largest export market.

In a statement, Trump said that only companies building manufacturing plants in the United States would be exempt from the tariffs. “Starting October 1st, 2025, we will be imposing a 100 per cent tariff on any branded or patented pharmaceutical product, unless a company is building the

See Full Page